ADGIPS2
ABBV icon

AmericaFirst Defensive Growth & Income Portfolio Series 2’s AbbVie ABBV Stock Holding History

AmericaFirst Defensive Growth & Income Portfolio Series 2’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$1.22M Buy
+16,826
New +$1.13M 1.54% 19

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AmericaFirst Defensive Growth & Income Portfolio Series 2's ABBV Position: Q2 2017 in Review

AmericaFirst Defensive Growth & Income Portfolio Series 2 opened a new position in AbbVie (ABBV) in Q2 2017: 16,826 shares worth $1.22M. The stake represents 1.54% of the portfolio and ranks #19 among its holdings.

1,763 funds tracked by Wall St. Rank hold ABBV as of Q2 2017.

  • AmericaFirst Defensive Growth & Income Portfolio Series 2 held 16,826 shares of AbbVie worth $1.22M as of Q2 2017.
  • AbbVie was a new AmericaFirst Defensive Growth & Income Portfolio Series 2 position in Q2 2017.
  • AbbVie made up 1.54% of AmericaFirst Defensive Growth & Income Portfolio Series 2's portfolio in Q2 2017, its #19 holding.
  • 1,763 funds tracked by Wall St. Rank held AbbVie as of Q2 2017.

Based on AmericaFirst Defensive Growth & Income Portfolio Series 2's 13F filing for Q2 2017, filed 15 Aug 2017.